Shanghai will build a China FDA medicine evaluation center to accelerate drug approvals, CNTV said on its official, as part of its efforts to continue to attract biotechnology and pharmaceutical firms to Shanghai and China.
China has faced challenges with a backlog of more than 18,500 drugs awaiting approval by the end of 2014, an increase of 33% from 2013, according to the China FDA's Center for Drug Evaluation in April 2015.
According to CNTV, the CFDA says the process of clinical trial and production application takes 240 working days in total. But domestic and multinational companies complain the waits are often double. CNTV says one key reason for delays is that CFDA has around 120 staff handling evaluations, compared to thousands at the U.S. FDA.